HQH ETF

HQH ETF
See how much of HQH you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free
Showing the top 10 of 133 holdings
Top 10 weight
38.59%
HQH top 10 holdings, by weight
#TickerNameWeightCumulative
1
GILD
Gilead Sciences Inc
6.44%
6.4%
2
AMGN
Amgen Inc
5.97%
12.4%
3
REGN
Regeneron Pharmaceuticals Inc
5.91%
18.3%
4
VRTX
Vertex Pharmaceuticals Inc
3.96%
22.3%
5
LLY
Eli Lilly & Co
3.57%
25.9%
6
BMRN
BioMarin Pharmaceutical Inc
2.92%
28.8%
7
ALNY
Alnylam Pharmaceuticals Inc
2.77%
31.5%
8
UNH
UnitedHealth Group Inc
2.77%
34.3%
9
GVMXX
State Street Global Advisors
2.23%
36.5%
10
ABT
Abbott Laboratories
2.05%
38.6%
More holdings · Pro
FundXLS Pro
See the other 123 holdings of HQH
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

HQH ETF Top Holdings

HQH holdings top 10 positions. The top 10 holdings account for 38.6% of the fund, led by Gilead Sciences Inc at 6.4%, Amgen Inc at 6.0%, Regeneron Pharmaceuticals Inc at 5.9%.

HQH portfolio concentration is moderate, with the top 10 representing 38.6% of total assets.

HQH sectors provide a detailed breakdown. HQH overlap shows how holdings compare to other funds in your portfolio.

Showing 10 of 133 holdingsTop 10 Weight: 38.59%
#TickerNameIndustryWeightAllocation
1GILDGilead Sciences IncUnknown6.44%
2AMGNAmgen IncUnknown5.97%
3REGNRegeneron Pharmaceuticals IncUnknown5.91%
4VRTXVertex Pharmaceuticals IncUnknown3.96%
5LLYEli Lilly & CoUnknown3.57%
6BMRNBioMarin Pharmaceutical IncUnknown2.92%
7ALNYAlnylam Pharmaceuticals IncUnknown2.77%
8UNHUnitedHealth Group IncUnknown2.77%
9GVMXXState Street Global AdvisorsUnknown2.23%
10ABTAbbott LaboratoriesUnknown2.05%
Want to see all 133 holdings?

Holdings Distribution

Loading chart...